Quality & complianceOfficial

BfArM publishes urgent field safety notice for Boston Scientific's Vercise Neural Navigator 5 software

🇩🇪 BfArM field safety notices · Tue 10 Nov 2026

Germany's regulator has listed a manufacturer safety notice for the deep brain stimulation programming software, but the public entry gives no detail on the issue or required actions.

The German Federal Institute for Drugs and Medical Devices (BfArM) has published an Urgent Field Safety Notice from Boston Scientific Neuromodulation Corporation concerning its Vercise Neural Navigator 5 software. The entry is dated 10 November 2026 and carries the reference 51694/26.

BfArM files the notice under active implantable medical devices, in the biostimulators product group. The summary on file describes the software as a programming tool for deep brain stimulation.

The BfArM web entry itself does not describe the problem, the affected versions or any action users should take. It refers readers to the manufacturer's Advisory Notice, which is attached as a 447 KB PDF. BfArM notes that the file does not meet accessibility standards.

As general context, a field safety notice is the document a manufacturer sends to customers when it takes a field safety corrective action on a marketed medical device. Regulators such as BfArM make these notices publicly available.

What it means for your team

  • Quality and regulatory teams with Vercise systems should obtain and read the full Advisory Notice, since the BfArM listing does not state the issue or required actions.
  • Vigilance staff should check whether the notice is relevant to their device inventory or clinical sites, and record any resulting actions under their field safety procedures.
  • Use reference 51694/26 and the 10 November 2026 publication date when documenting the notice.

Official source: BfArM field safety notices ↗

Article written by VigiEye from the official source (BfArM field safety notices). AI-assisted; check the source before acting.

More Quality & compliance All →